NCT06540872View on ClinicalTrials.gov

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Carcinoma, Intraductal, Noninfiltrating
Interventions
DRUG

[68Ga]Ga-FAPI-46

Participants receive the weakly radioactive drug \[68Ga\]Ga-FAPI-46 through their vein and lie in an imaging device (PET/MRI) for 30 minutes. After a break of 30 minutes, they will lie in the imaging device for another 15 minutes.

Trial Locations (2)

45147

Department of Nuclear Medicine, University Hospital Essen, Essen

48149

Department of Nuclear Medicine, University Hospital Münster, Münster

All Listed Sponsors
lead

Universität Münster

OTHER